Bio Green Med Solution, Inc. — Director's Dealing 2020

Oct 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2020-10-23

Reporting Person: Kirschbaum Mark (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-23	Stock Option (right to buy)	$3.77	A	120000	Acquired	2030-10-23	Common Stock (120000)	Direct

Footnotes

F1: The shares underlying this option vest as to 40,000 shares on October 23, 2021, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.